Two Report Options

Integrated Molecular and First-line Results

Molecular-only Results

Look Below the Surface

With Molecular Testing

Two Report Options

Integrated Molecular and First-line Results

Molecular-only Results

Look Below the Surface

With Molecular Testing

Request Information

I am interested in:

Interest

Learning more about PancraGEN/PanDNA Understanding how to order and use test collection materials Requesting a visit from my representative Other

NPI

(Needed for verification purposes to allow representative follow‑up)

Name

Email

Phone Number

Zip Code

Limitations and Disclaimers¹
Although PancraGEN is highly specific for malignancy, some malignant cysts may not be detected. There may also be individuals who are falsely identified as having a malignant cyst. Diagnosis and appropriate patient management are the responsibility of the referring physician or healthcare provider.

Reference 1. Al-Haddad MA, Kowalski T, Siddiqui A, et al. Integrated molecular pathology accurately determines the malignant potential of pancreatic cysts. Endoscopy. 2015;47(2):136-142.

Interpace Diagnostics is a registered trademark and business unit of Interpace Biosciences, Inc.™
©2023 Interpace Biosciences, Inc.™ All rights reserved.
Privacy Policy | HIPAA Privacy